Everyone recognises the importance of strategy. It’s essential in many areas, not least patient-reported outcomes (PRO) measurement. A PRO strategy is a carefully constructed method of evaluating new treatments from the patients’ perspective. It is an integral part of product development, incorporating the design, implementation, delivery and communication of PROs.
It is important to treat decisions involving PROs in a similar way to other outcomes measured in clinical research. The process needs to be systematic and transparent, and follow principles of good scientific practice, rather than short-term reactions to guidelines or regulations.
A robust PRO strategy is crucial to the successful evaluation of any treatment or intervention from the patients’ perspective. It guides the appropriate selection and interpretation of PRO measures, and ensures the investment in implementation and evaluation of programmes is justified and offers optimal returns.